PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|November 19, 2009
AAPS 2009:Innovations - Antimetastatic Lead Phenylmethylene Hydantoins
Advertisement
A Joint Presentation of Pharmaceutical Technology and
Young Innovators of 2009: Interviews with AAPS Graduate Student Winners
Antimetastatic Lead Phenylmethylene Hydantoins
Subscribe to RSS feed of this series
Mudit Mudit
University of Louisiana, Monroe
Category: DRUG DESIGN AND DISCOVERY
Discovery, Design, and Synthesis of Antimetastatic Lead Phenylmethylene Hydantoins
View Poster Presentation
Related Articles
Winning Presentations
Listen to the Interviews
AAPS President
Dr. Patrick P. DeLuca, president of AAPS, discusses the organization’s programs and commitment to student scientists.
Listen>>
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement